GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (FRA:AX1) » Definitions » EV-to-EBITDA

Sipai Health Technology Co (FRA:AX1) EV-to-EBITDA : -18.27 (As of May. 04, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sipai Health Technology Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sipai Health Technology Co's enterprise value is €444.6 Mil. Sipai Health Technology Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-24.3 Mil. Therefore, Sipai Health Technology Co's EV-to-EBITDA for today is -18.27.

The historical rank and industry rank for Sipai Health Technology Co's EV-to-EBITDA or its related term are showing as below:

FRA:AX1' s EV-to-EBITDA Range Over the Past 10 Years
Min: -19.35   Med: -0.52   Max: 0.7
Current: -18.01

During the past 3 years, the highest EV-to-EBITDA of Sipai Health Technology Co was 0.70. The lowest was -19.35. And the median was -0.52.

FRA:AX1's EV-to-EBITDA is ranked worse than
100% of 80 companies
in the Medical Distribution industry
Industry Median: 9.965 vs FRA:AX1: -18.01

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-04), Sipai Health Technology Co's stock price is €0.705. Sipai Health Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.051. Therefore, Sipai Health Technology Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Sipai Health Technology Co EV-to-EBITDA Historical Data

The historical data trend for Sipai Health Technology Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co EV-to-EBITDA Chart

Sipai Health Technology Co Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBITDA
- -8.59 -19.84

Sipai Health Technology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA - - -8.59 - -19.84

Competitive Comparison of Sipai Health Technology Co's EV-to-EBITDA

For the Medical Distribution subindustry, Sipai Health Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sipai Health Technology Co's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's EV-to-EBITDA falls into.



Sipai Health Technology Co EV-to-EBITDA Calculation

Sipai Health Technology Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=444.567/-24.327
=-18.27

Sipai Health Technology Co's current Enterprise Value is €444.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-24.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sipai Health Technology Co  (FRA:AX1) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sipai Health Technology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.705/-0.051
=At Loss

Sipai Health Technology Co's share price for today is €0.705.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.051.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Sipai Health Technology Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co (FRA:AX1) Business Description

Traded in Other Exchanges
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.

Sipai Health Technology Co (FRA:AX1) Headlines

No Headlines